The relationship between naloxone-induced cortisol and delta opioid receptor availability in mesolimbic structures is disrupted in alcohol-dependent subjects

Addiction Biology

Volumn 18, Issue 1, 2013, Pages 181-192

  Wand, Gary S ^a   Weerts, Elise M ^a   Kuwabara, Hiroto ^a   Wong, Dean F ^a   Xu, Xiaoqiang ^a   McCaul, Mary E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cortisol; delta opioid receptors; HPA axis; mu opioid receptors; naloxone; PET imaging

Indexed keywords

CORTICOTROPIN; DELTA OPIATE RECEPTOR; HYDROCORTISONE; METHYL NALTRINDOLE C 11; NALOXONE; NALTRINDOLE; UNCLASSIFIED DRUG;

ADULT; ALCOHOLISM; ANTERIOR CINGULATE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOTROPIN BLOOD LEVEL; FEMALE; FUSIFORM GYRUS; HUMAN; HYPOTHALAMUS; LIMBIC CORTEX; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; TEMPORAL CORTEX;

ADRENOCORTICOTROPIC HORMONE; ADULT; ALCOHOLISM; AREA UNDER CURVE; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIGANDS; LIMBIC SYSTEM; LINEAR MODELS; MALE; MIDDLE AGED; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; PITUITARY-ADRENAL SYSTEM; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, OPIOID, DELTA; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84871754594     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2011.00430.x     Document Type: Article

References (68)

1. al'Absi M, Wittmers LE, Hatsukami D, Westra R, (2008) Blunted opiate modulation of hypothalamic-pituitary-adrenocortical activity in men and women who smoke. Psychosom Med 70: 928-935.
2. Adinoff B, Krebaum SR, Chandler PA, Ye W, Brown MB, Williams MJ, (2005) Dissection of hypothalamic-pituitary-adrenal pathology in one-month abstinent alcohol-dependent men: response to CRH and Naloxone. Alcohol Clin Exp Res 29: 528-537.
3. Barson JR, Carr AJ, Soun JE, Sobhani NC, Leibowitz SF, Hoebel BG, (2009) Opioids in the nucleus accumbens stimulate ethanol intake. Physiol Behav 98: 453-459.
4. Barson JR, Carr AJ, Soun JE, Sobhani NC, Rada P, Leibowitz SF, Hoebel BG, (2010) Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake. Alcohol Clin Exp Res 34: 214-222.
5. Berrendero F, Robledo P, Trigo JM, Martín-García E, Maldonado R, (2010) Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system. Neurosci Biobehav Rev 35: 220-231.
6. Borsook D, Hyman SE, (1995) Proenkephalin gene regulation in the neuroendocrine hypothalamus: a model of gene regulation in the CNS. Am J Physiol 269: E393-E408.
7. Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger JI Jr, Reich T, Schmidt I, Schuckit MA, (1994) A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol 55: 149-158.
8. Ceccatelli S, Orazzo C, (1993) Effect of different types of stressors on peptide messenger ribonucleic acids in the hypothalamic paraventricular nucleus. Acta Endocrinol 128: 485-492.
9. Cometta-Morini C, Maguire PA, Loew GH, (1992) Molecular determinants of mu receptor recognition for the fentanyl class of compounds. Mol Pharmacol 41: 185-196.
10. Dawson DA, (2000) Drinking as a risk factor for sustained smoking. Drug Alcohol Depend 59: 235-249.
11. Drolet G, Dumont EC, Gosselin I, Kinkead R, Laforest S, Trottier JF, (2001) Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol Biol Psychiatry 25: 729-741.
12. Fallon JH, Leslie FM, (1986) Distribution of dynorphin and enkephalin peptides in the rat brain. J Comp Neurol 249: 293-336.
13. Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K, Gavériaux-Ruff C, Dierich A, LeMeur M, Valverde O, Maldonado R, Kieffer BL, (2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25: 195-200.
14. Franck J, Lindholm S, Raaschou P, (1998) Modulation of volitional ethanol intake in the rat by central delta-opioid receptors. Alcohol Clin Exp Res 22: 1185-1189.
15. Froehlich JC, Zweifel M, Harts J, Lumeng L, Li TK, (1991) Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology 103: 467-472.
16. Frost JJ, Mayberg HS, Sadzot B, Dannals RF, Lever JR, Ravert HT, Wilson AA, Wagner HN Jr, Links JM, (1990) Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography. J Cereb Blood Flow Metab 10: 484-492.
17. Guthrie J, Basbaum A, (1984) Colocalization of immunoreactive proenkephalin and prodynorphin products in medullary neurons of the rat. Neuropeptides 4: 437-445.
18. Harlan RE, Shivers BD, Romano GJ, Howells RD, Pfaff DW, (1987) Localization of proenkephalin mRNA in the rat brain and spinal cord by in situ hybridization. J Comp Neurol 258: 159-184.
19. Hebb A, Zacharko RM, Gauthier M, Trudei F, LaForest S, Drolet G, (2004) Brief exposure to predator odor and resultant anxiety enhances mesocorticolimbic activity and enkephalin expression in CD-1 mice. Eur Neurosci 20: 2415-2418.
20. Hilton J, Yokoi F, Dannals RF, Ravert HT, Szabo Z, Wong DF, (2000) Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol 27: 627-630.
21. Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N, (2005) Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Neuroscience 135: 213-225.
22. Hochberg Y, Benjamin Y, (1990) More powerful procedures for multiple significance testing. Stat Med 9: 811-818.
23. Hurd YL, (1996) Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain. Neuroscience 72: 767-783.
24. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE, (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27: 1533-1539.
25. Jankord R, Herman JP, (2008) Limbic regulation of hypothalamo-pituitary- adrenocortical function during acute and chronic stress. Ann N Y Acad Sci 148: 64-73.
26. Janssens CJ, Helmond FA, Loyens LW, Schouten WG, Wiegant VM, (1995) Chronic stress increases the opioid-mediated inhibition of the pituitary-adrenocortical response to acute stress in pigs. Endocrinology 136: 1468-1473.
27. Khachaturian H, Lewis M, Watson SJ, (1983) Enkephalin systems in the diencephalon and brainstem of the rat. J Comp Neurol 220: 310-320.
28. Kinahan PE, Rogers JG, (1989) Analytic 3D image reconstruction using all detected events. IEEE Trans Nucl Sci 36: 964-968.
29. Konig M, Zimmer AM, Steiner H, Holmes PV, Crawley JN, Brownstein MJ, Zimmer A, (1996) Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383: 535-538.
30. Kranzler HR, Edenberg HJ, (2010) Pharmacogenetics of alcohol and alcohol dependence treatment. Curr Pharm Des 16: 2141-2148.
31. Krishnan-Sarin S, Portoghese PS, Li TK, Froehlich JC, (1995) The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol Biochem Behav 52: 153-159.
32. Lewanowitsch T, Irvine RJ, (2003) Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for mu, delta, and kappa opioid receptors in mouse brain homogenates. Brain Res 964: 302-305.
33. Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, MacGregor RR, Hitzemann R, Bendriem B, Gatley SJ, (1990) Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10: 740-747.
34. Madar I, Lesser RP, Krauss G, Zubieta JK, Lever JR, Kinter CM, Ravert HT, Musachio JL, Mathews WB, Dannals RF, Frost JJ, (1997) Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. Ann Neurol 41: 358-367.
35. Mangold D, McCaul M, Ali M, Wand GS, (2000) Generating a dose response curve to naloxone in a single session. Biol Psychiatry 48: 310-314.
36. Mangold D, Wand G, (2006) Cortisol and ACTH responses to naloxone in subjects with high and low neuroticism. Biol Psychiatry 60: 850-855.
37. Marinelli PW, Funk D, Harding S, Li Z, Juzytsch W, Lê AD, (2009) Roles of opioid receptor subtypes in mediating alcohol-seeking induced by discrete cues and context. Eur J Neurosci 4: 671-678.
38. Meltzer CC, Bryan RN, Holcomb HH, Kimball AW, Mayberg HS, Sadzot B, Leal JP, Wagner HN Jr, Frost JJ, (1990) Anatomical localization for PET using MR imaging. J Comput Assist Tomogr 14: 418-426.
39. Méndez M, Morales-Mulia M, (2008) Role of mu and delta opioid receptors in alcohol drinking behaviour. Curr Drug Abuse Rev 1: 239-252.
40. Micevych PE, Eckersell CB, Brecha N, Holland KL, (1997) Estrogen modulation of opioid and cholecystokinin systems in the limbic-hypothalamic circuit. Brain Res Bull 44: 335-343.
41. Narita M, Kuzumaki N, Narita M, Kaneko C, Hareyama N, Miyatake M, Shindo K, Miyoshi K, Nakajima M, Nagumo Y, Sato F, Wachi H, Seyama Y, Suzuki T, (2006) Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction. J Neurochem 97: 1369-1378.
42. Nielsen CK, Simms JA, Bito-Onon JJ, Li R, Ananthan S, Bartlett SE, (2011) The delta opioid receptor antagonist, SoRI-9409, decreases yohimbine stress-induced reinstatement of ethanol-seeking. Addict Biol [Epub ahead of print].
43. Oswald L, Wand G, (2004) Opioids and alcohol. Physiol Behav 81: 339-358.
44. Petrusz P, Merchenthaler I, Maderdrut JL, (1985) Distribution of enkephalin-containing neurons in the central nervous system. In:, Björklund A, Hökfelt T, eds. Handbook of Chemical Neuroanatomy, pp. 273-334. Amsterdam: Elsevier Science.
45. Portoghese PS, Sultana M, Takemori AE, (1990) Design of peptidomimetic delta opioid receptor antagonists using the message-address concept. J Med Chem 33: 1714-1720.
46. Radua J, Phillips M, Tamara R, Lawrence N, Marshall N, Kalidindi S, El-Hage W, McDonald C, Giampietro V, Brammer MJ, David AS, Surguladze SA, (2010) Neural response to specific components of fearful faces in healthy and schizophrenic adults. Neuroimage 49: 939-946.
47. Roche DJ, Childs E, Epstein AM, King AC, (2010) Acute HPA axis response to naltrexone differs in female vs. male smokers. Psychoneuroendocrinology 35: 596-606.
48. Schluger JH, Ho A, Borg L, Porter M, Maniar S, Gunduz M, Perret G, King A, Kreek MJ, (1998) Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism. Alcohol Clin Exp Res 7: 1430-1436.
49. Skinner HA, Allen BA, (1982) Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 91: 199-209.
50. Sobell LC, Sobell MB, (1992) Timeline followback: a technique for assessing self-reported alcohol consumption. In:, Litten RZ, Allen J, eds. Measuring Alcohol Consumption: Psychosocial and Biological Methods, pp. 41-72. Clifton, NJ: Humana Press.
51. Stephens M, Wand G, (2011) Stress and Alcohol Use Disorders: The Role of Glucocorticoids. Washington, DC: National Institutes of Health's Alcohol Health Research (in press).
52. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM, (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84: 1353-1357.
53. Szekely JL, (1990) Opioid peptides and stress. Crit Rev Neurobiol 6: 1-12.
54. Titeler M, Lyon RA, Kuhar MJ, Frost JF, Dannals RF, Leonhardt S, Bullock A, Rydelek LT, Price DL, Struble RG, (1989) Mu opiate receptors are selectively labelled by [3H]carfentanil in human and rat brain. Eur J Pharmacol 167: 221-228.
55. Traynor JR, Hunter JC, Rodriguez RE, Hill RG, Hughes J, (1990) Delta-opioid receptor binding sites in rodent spinal cord. Br J Pharmacol 100: 319-323.
56. Uhart M, Chong R, Oswald L, Ping L, Wand GS, (2006) Gender differences in hypothalamic-pituitary-adrenal (HPa) axis reactivity. Psychoneuroendocrinology 31: 642-652.
57. Wand GS, (2008) The influence of stress on the transition from drug use to addiction. Natl Inst Health's Alcohol Health Res 31: 119-136.
58. Wand GS, Mangold D, Ali M, (1999) Adrenocorticotropin response to naloxone in sons of alcohol dependent men. J Clin Endocrinol Metab 84: 64-68.
59. Wand GS, Mangold D, El Diery S, McCaul M, Hoover D, (1998) Family history of alcoholism and hypothalamic opioidergic activity. Arch Gen Psychiatry 55: 1114-1119.
60. Wand GS, McCaul M, Gotjen D, Reynolds J, Lee S, (2001) Confirmation that offspring from families with alcohol dependent individuals have greater HPA axis activation-induced by naloxone compared to offspring without a family history of alcohol dependence. Alcohol Clin Exp Res 25: 1134-1139.
61. Wand GS, McCaul M, Gotjen D, Reynolds J, Lee S, (2002) The mu opioid receptor gene polymorphism A(118)G alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 26: 106-114.
62. Wand G, Weerts E, Kuwabara H, Frost JJ, Xu X, McCaul ME, (2011) Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions. Psychoneuroendocrinology 36: 1453-1459.
63. Watson SJ, Khachaturian H, Akil H, Coy DH, Goldstein A, (1982) Comparison of the distribution of dynorphin systems and enkephalin systems in brain. Science 218: 1134-1136.
64. Watts A, (1991) Ether anesthesia differentially affects the content of prepro-corticotropin-releasing hormone, prepro-neurotensin/neuromedin N and prepro-enkephalin mRNAs in the hypothalamic paraventricular nucleus of the rat. Brain Res 544: 353-357.
65. Weerts E, Kim Y, Wand G, Dannals R, Lee J, Frost J, McCaul M, (2008) Differences in mu- and delta opioid receptor blockade measured by PET in Naltrexone-treated recently abstinent alcohol dependent subjects. Neuropsychopharmacology 33: 653-665.
66. Weerts EM, Wand G, Kuwabara H, Munro CA, Dannals DF, Hilton J, Frost JJ, McCaul ME, (2011) PET imaging of mu- and delta-opioid receptor binding in alcohol dependent and healthy control subjects. Alcohol Clin Exp Res 35: 2162-2173.
67. Wise RA, (2008) Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 14: 169-183.
68. Young E, Lightman M, (1992) Chronic stress elevates enkephalin expression in the rat paraventricular and supraoptic nuclei. Mol Brain Res 13: 111-117.